Alexithymia in Alzheimer’s Disease
Autor: | Alejandra Rebeca Melero Ventola, Eva M. Arroyo-Anlló, Corinne Souchaud, Pierre Ingrand, Jorge Chamorro Sánchez, Roger Gil |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2021 |
Předmět: |
media_common.quotation_subject
emotion lcsh:Medicine Article 03 medical and health sciences Toronto Alexithymia Scale 0302 clinical medicine Alexithymia Rating scale medicine Dementia awareness neurodegenerative diseases Cognitive skill media_common language medicine.diagnostic_test business.industry lcsh:R Cognition General Medicine Neuropsychological test medicine.disease 030227 psychiatry Feeling depression Alzheimer business 030217 neurology & neurosurgery Clinical psychology dementia |
Zdroj: | Journal of Clinical Medicine, Vol 10, Iss 44, p 44 (2021) Journal of Clinical Medicine Volume 10 Issue 1 |
ISSN: | 2077-0383 |
Popis: | Alexithymia is widely recognized as the inability to identify and express emotions. It is a construct which consists of four cognitive traits such as difficulty in identifying feelings, describing feelings to others, externally oriented thinking, and limited imaginative capacity. Several studies have linked alexithymia to cognitive functioning, observing greater alexithymia scores associated with poorer cognitive abilities. Despite Alzheimer&rsquo s disease (AD) being a neurodegenerative pathology characterized by cognitive troubles from the early stages, associated to behavioral and emotional disturbances, very few investigations have studied the alexithymia in AD. These studies have shown that alexithymia scores&mdash assessed with Toronto Alexithymia Scale (TAS)&mdash were greater in AD patients than healthy participants. The objective of the study was to investigate if the alexithymia was present in patients with mild AD. We hypothesized that the AD group would show more alexithymia features than the control group. We evaluated 54 subjects, including 27 patients diagnosed with mild AD and 27 normal healthy controls, using the Shalling Sifneos Psychosomatic Scale (SSPS-R) and a neuropsychological test battery. Using non-parametric statistical analyses&mdash Wilcoxon and Mann&ndash Whitney U tests&mdash we observed that the SSPS-R scores were similar in the AD and control groups. All participants showed SSPS-R scores below to 10 points, which means no-alexithymia. We did not find significant correlations between SSPS-R scores and cognitive variables in both groups (p > 0.22), but we observed a negative association between name abilities and alexithymia, but it does not reach to significance (p = 0.07). However, a significant correlation between SSPS-R score and mood state, assessed using Zerssen Rating Scale, was found in both groups (p = 0.01). Because we did not find a significant difference in the alexithymia assessment between both subject groups, pot hoc analyses were computed for each item of the SSPS-R. We made comparisons of alexithymic responses percentages in each SSPS-R item between AD and control groups, using Fisher&rsquo s test. We observed that AD patients produced more alexithymic responses in some items of SSPS-R test than the control group, particularly about difficulties to find the words to describe feelings, as well as difficulties of imagination capacity and externally oriented thinking. The present results do not confirm our hypothesis and they do not support the results of previous studies revealing great alexithymia in AD. |
Databáze: | OpenAIRE |
Externí odkaz: |